Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease

Clinical Nutrition

Volumn 35, Issue 1, 2016, Pages 175-182

  Jegatheesan, Prasanthi ^a   Beutheu, Stéphanie ^a   Ventura, Gabrielle ^a   Sarfati, Gilles ^b   Nubret, Esther ^a   Kapel, Nathalie ^a   Waligora Dupriet, Anne Judith ^a   Bergheim, Ina ^c   Cynober, Luc ^a,b   De Bandt, Jean Pascal ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Arginine; Citrulline; Glutamine; Non alcoholic fatty liver disease

Indexed keywords

ALANINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ARGININE; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; BILIRUBIN; CHOLESTEROL; CITRULLINE; FRUCTOSE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; INSULIN; LIPID; MYELOPEROXIDASE; NITROGEN; PROLINE; SERINE; TIGHT JUNCTION PROTEIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; MESSENGER RNA; TLR4 PROTEIN, RAT; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM; CECUM; CONTROLLED STUDY; DIETARY INTAKE; ENDOTOXEMIA; ENTERITIS; ENZYME ACTIVITY; GLUCOSE HOMEOSTASIS; HEPATITIS; HISTOLOGY; HYPERTRIGLYCERIDEMIA; INTESTINE ABSORPTION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER FUNCTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED; DIETARY SUPPLEMENT; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; SPRAGUE DAWLEY RAT;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ARGININE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BLOOD GLUCOSE; CHOLESTEROL; CITRULLINE; DIETARY SUPPLEMENTS; FRUCTOSE; GLUTAMINE; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; INTESTINAL ABSORPTION; LIPID METABOLISM; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923561416     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.01.021     Document Type: Article

References (30)

1. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
2. Tappy L., Lê K.-A. Does fructose consumption contribute to non-alcoholic fatty liver disease?. Clin Res Hepatol Gastroenterol 2012, 36:554-560.
3. Spruss A., Bergheim I. Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem 2009, 20:657-662.
4. Spruss A., Kanuri G., Wagnerberger S., Haub S., Bischoff S.C., Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 2009, 50:1094-1104.
5. Abu-Shanab A., Quigley E.M.M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010, 7:691-701.
6. Marc Rhoads J., Wu G. Glutamine, arginine, and leucine signaling in the intestine. Amino Acids 2009, 37:111-122.
7. Wu G., Bazer F.W., Davis T.A., Kim S.W., Li P., Marc Rhoads J., et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009, 37:153-168.
8. Adawi D., Kasravi F.B., Molin G., Jeppsson B. Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology 1997, 25:642-647.
9. De-Souza D.A., Greene L.J. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med 2005, 33:1125-1135.
10. Li N., Lewis P., Samuelson D., Liboni K., Neu J. Glutamine regulates Caco-2 cell tight junction proteins. Am J Physiol Gastrointest Liver Physiol 2004, 287:G726-G733.
11. Coëffier M., Marion R., Ducrotté P., Déchelotte P. Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clin Nutr 2003, 22:407-413.
12. Cynober L., Moinard C., De Bandt J.-P. The 2009 ESPEN Sir David Cuthbertson. Citrulline: a new major signaling molecule or just another player in the pharmaconutrition game?. Clin Nutr 2010, 29:545-551.
13. Moinard C., Le Plénier S., Cynober L., Raynaud-Simon A. Long-term effect of citrulline supplementation in healthy aged rats: effect on body composition. Clin Nutr Suppl 2009, 4:12.
14. Osowska S., Neveux N., Nakib S., Lasserre V., Cynober L., Moinard C. Impairment of arginine metabolism in rats after massive intestinal resection: effect of parenteral nutrition supplemented with citrulline compared with arginine. Clin Sci 2008, 115:159-166.
15. Osowska S., Duchemann T., Walrand S., Paillard A., Boirie Y., Cynober L., et al. Citrulline modulates muscle protein metabolism in old malnourished rats. Am J Physiol Endocrinol Metab 2006, 291:E582-E586.
16. Van De Kamer J.H., Ten Bokkel Huinink H., Weyers H.A. Rapid method for the determination of fat in feces. J Biol Chem 1949, 177:347-355.
17. Barone F.C., Hillegass L.M., Price W.J., White R.F., Lee E.V., Feuerstein G.Z., et al. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res 1991, 29:336-345.
18. Beutheu Youmba S., Belmonte L., Galas L., Boukhettala N., Bôle-Feysot C., Déchelotte P., et al. Methotrexate modulates tight junctions through NF-κB, MEK, and JNK pathways. J Pediatr Gastroenterol Nutr 2012, 54:463-470.
19. Kalach N., Kapel N., Waligora-Dupriet A.-J., Castelain M.-C., Cousin M.O., Sauvage C., et al. Intestinal permeability and fecal eosinophil-derived neurotoxin are the best diagnosis tools for digestive non-IgE-mediated cow's milk allergy in toddlers. Clin Chem Lab Med 2013, 51:351-361.
20. Basciano H., Federico L., Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005, 2:5.
21. Jürgens H., Haass W., Castañeda T.R., Schürmann A., Koebnick C., Dombrowski F., et al. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res 2005, 13:1146-1156.
22. Basaranoglu M., Basaranoglu G., Sabuncu T., Senturk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol 2013, 19:1166-1172.
23. Theytaz F., Noguchi Y., Egli L., Campos V., Buehler T., Hodson L., et al. Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans. Am J Clin Nutr 2012, 96:1008-1016.
24. Stepien M., Gaudichon C., Fromentin G., Even P., Tomé D., Azzout-Marniche D. Increasing protein at the expense of carbohydrate in the diet down-regulates glucose utilization as glucose sparing effect in rats. PLoS ONE 2011, 6:e14664.
25. De Bandt J.-P., Waligora-Dupriet A.-J., Butel M.-J. Intestinal microbiota in inflammation and insulin resistance: relevance to humans. Curr Opin Clin Nutr Metab Care 2011, 14:334-340.
26. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
27. Bergheim I., Weber S., Vos M., Krämer S., Volynets V., Kaserouni S., et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 2008, 48:983-992.
28. Guelzim N., Mariotti F., Martin P.G.P., Lasserre F., Pineau T., Hermier D. A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis. Amino Acids 2011, 41:969-979.
29. El-Bassossy H.M., El-Fawal R., Fahmy A., Watson M.L. Arginase inhibition alleviates hypertension in the metabolic syndrome. Br J Pharmacol 2013, 169:693-703.
30. Joffin N., Jaubert A.M., Durant S., Bastin J., De Bandt J.-P., Cynober L., et al. Citrulline induces fatty acid release selectively in visceral adipose tissue from old rats. Mol Nutr Food Res 2014, 58:1765-1775.